The results of NanoViricide, Inc.’s research into anti-Ebola agents were presented on July 17 to the Annual Meeting of the American Society for Virology at Montana State University in Bozeman, Montana.
The results of NanoViricide, Inc.’s research into anti-Ebola agents were presented on July 17 to the Annual Meeting of the American Society for Virology at Montana State University in Bozeman, Montana.
Researchers recently announced that they have designed a vaccine that protects monkeys from at least three different strains of the Ebola virus.
SAN ANTONIO — The Southwest Foundation for Biomedical Research announced Jan. 6 that it has received a contract from the Dutch pharmaceutical firm Crucell to test a vaccine against Ebola and Marburg viruses, which cause hemorrhagic fevers.
KANDAHAR, Afghanistan — U.S. military officials sent a medical team to a remote outpost in southern Afghanistan this week to take blood samples from members of an Army unit after a soldier in the unit died from an Ebola-like virus.